Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections

Sponsor
Inova Health Care Services (Other)
Overall Status
Terminated
CT.gov ID
NCT01028105
Collaborator
Cardinal Health (Industry)
975
2
2
68
487.5
7.2

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the prevalence of pre-surgical patients who are MRSA carriers. From an evidence-based practice perspective, findings from this study can be considered in the evaluation of the hospital SOP mandating pre-surgical MRSA screening requirements for patients with scheduled surgeries.

The central hypothesis to be addressed in this study is whether the MRSA colonization and subsequent post-operative infection are the equivalent in these populations.

Condition or Disease Intervention/Treatment Phase
  • Other: Preoperative MRSA screening
N/A

Detailed Description

Design and Methods: Subjects in this study of 975 pre-operative, scheduled surgical patients are in one of the three following groups:

  • Group 1 (N=325): Allocation sample of surgical patients required to be MRSA screened per hospital SOP (including patients having a positive MRSA history, orthopedic surgery, undergoing dialysis, or transfer from another hospital, nursing home, skilled nursing facility, or jail).

  • Group 2 (N=650): Randomized sample (1:1 ratio) of surgical patients not required to be

MRSA screened per hospital SOP, to one of the following two groups:
  • 2a (N=325): MRSA screening; or

  • 2b (N=325): No MRSA screening. All subjects were followed for 30 days post-operatively to determine the incidence of post-operative infection. Treatment, diagnostic, and hospitalization data were collected for patients diagnosed with post-operative infection.

Study Design

Study Type:
Interventional
Actual Enrollment :
975 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluation of the Prevalence of Methicillin Resistant Staphylococcus Aureus Colonization in Pre-Surgical Patients and Post-Operative Infection
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
Jan 1, 2011
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No MRSA screening, Group b

Standard of care

Other: MRSA screening, Group a

MRSA preoperative screening

Other: Preoperative MRSA screening
MRSA preoperative screening and post operative infection rate, 30 days post operative

Outcome Measures

Primary Outcome Measures

  1. The primary objective of this study is to compare the prevalence of MRSA colonization and its relationship to post-operative infection in patients who are currently pre-operatively MRSA screened per SOP to those who are not. [30 days]

Secondary Outcome Measures

  1. The secondary objective is to compare medical charges associated with diagnosis and treatment of post-operative infections for these groups using cost-effectiveness analysis. [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Pre-surgical out patient at ILH

  2. Surgical procedure scheduled at least 2 days before surgery

  3. Surgery being done at ILH operating room

  4. Provision of signed ICF

Exclusion Criteria:
  1. Patient 18 years of age or older who is deemed by the hospital incapable of providing Informed Consent

  2. Inability to communicate in the English language

Contacts and Locations

Locations

Site City State Country Postal Code
1 Inova Health Care Services Falls Church Virginia United States 22042
2 Inova Loudoun Hospital Leesburg Virginia United States 20176

Sponsors and Collaborators

  • Inova Health Care Services
  • Cardinal Health

Investigators

  • Study Director: Karen G Speroni, BSN, MHSA, PhD, Inova Loudoun Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cynthia Hack, Principal Investigator, Inova Health Care Services
ClinicalTrials.gov Identifier:
NCT01028105
Other Study ID Numbers:
  • 08.003
First Posted:
Dec 9, 2009
Last Update Posted:
Jun 8, 2021
Last Verified:
Jun 1, 2021
Keywords provided by Cynthia Hack, Principal Investigator, Inova Health Care Services
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2021